|Choriodecidual infection downregulates angiogenesis and morphogenesis pathways in fetal lungs from Macaca nemestrina.|
|Jump to Full Text|
|PMID: 23056493 Owner: NLM Status: MEDLINE|
|BACKGROUND: Intrauterine exposure to amniotic fluid (AF) cytokines is thought to predispose to bronchopulmonary dysplasia (BPD). We evaluated the effects of GBS exposure on RNA expression in fetal lung tissue to determine early molecular pathways associated with fetal lung injury that may progress to BPD.
METHODS: Ten chronically catheterized pregnant monkeys (Macaca nemestrina) at 118-125 days gestation (term = 172 days) received choriodecidual inoculation of either: 1) Group B Streptococcus (n = 5) or 2) saline (n = 5). Cesarean section and fetal necropsy was performed in the first week after GBS or saline inoculation regardless of labor. RNA was extracted from fetal lungs and profiled by microarray. Results were analyzed using single gene, Gene Set, and Ingenuity Pathway Analysis. Validation was by RT-PCR and immunohistochemistry.
RESULTS: Despite uterine quiescence in most cases, fetal lung injury occurred in four GBS cases (intra-alveolar neutrophils, interstitial thickening) and one control (peri-mortem hemorrhage). Significant elevations of AF cytokines (TNF-α, IL-8, IL-1β, IL-6) were detected in GBS versus controls (p<0.05). Lung injury was not directly caused by GBS, because GBS was undetectable by culture and PCR in the AF and fetal lungs. A total of 335 genes were differentially expressed greater than 1.5 fold (p<0.05) with GBS exposure associated with a striking upregulation of genes in innate and adaptive immunity and downregulation of pathways for angiogenesis, morphogenesis, and cellular growth and development.
CONCLUSIONS: A transient choriodecidual infection may induce fetal lung injury with profound alterations in the genetic program of the fetal lung before signs of preterm labor. Our results provide a window for the first time into early molecular pathways disrupting fetal lung angiogenesis and morphogenesis before preterm labor occurs, which may set the stage for BPD. A strategy to prevent BPD should target the fetus in utero to attenuate alterations in the fetal lung genetic program.
|Ryan M McAdams; Jeroen Vanderhoeven; Richard P Beyer; Theo K Bammler; Federico M Farin; H Denny Liggitt; Raj P Kapur; Michael G Gravett; Craig E Rubens; Kristina M Adams Waldorf|
Related Documents :
|872423 - A specific direct radioimmunoassay for oestriol-16alpha-glucuronide in pregnancy plasma.
22482313 - A study of twins--in search of an optimal age for delivery.
23543613 - A study on tubal recanalization.
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2012-10-09|
|Title: PloS one Volume: 7 ISSN: 1932-6203 ISO Abbreviation: PLoS ONE Publication Date: 2012|
|Created Date: 2012-10-11 Completed Date: 2013-05-07 Revised Date: 2013-07-11|
Medline Journal Info:
|Nlm Unique ID: 101285081 Medline TA: PLoS One Country: United States|
|Languages: eng Pagination: e46863 Citation Subset: IM|
|Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.|
|APA/MLA Format Download EndNote Download BibTex|
Cytokines / metabolism
Fetus / embryology, microbiology*, physiology
Gene Expression Profiling
Lung / embryology*, microbiology
Morphogenesis / genetics*
Neovascularization, Physiologic / genetics*
Oligonucleotide Array Sequence Analysis
Placenta / microbiology
Pregnancy Complications / genetics*, metabolism, pathology, physiopathology
Saccule and Utricle / embryology
Streptococcal Infections / genetics*, metabolism, pathology, physiopathology
Streptococcus agalactiae / physiology
|AI00989/AI/NIAID NIH HHS; AI067910/AI/NIAID NIH HHS; HD-001264/HD/NICHD NIH HHS; HD-002274/HD/NICHD NIH HHS; R01 AI100989/AI/NIAID NIH HHS|
|PLoS One. 2013;8(2). doi: 10.1371/annotation/2832117a-0601-4416-a256-c7e64c541a0b
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Publisher: Public Library of Science, San Francisco, USA
Copyright: 2012 McAdams et al
Received Day: 16 Month: 7 Year: 2012
Accepted Day: 6 Month: 9 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 9 Month: 10 Year: 2012
Volume: 7 Issue: 10
E-location ID: e46863
PubMed Id: 23056493
Publisher Id: PONE-D-12-22693
|Choriodecidual Infection Downregulates Angiogenesis and Morphogenesis Pathways in Fetal Lungs from Macaca Nemestrina Alternate Title:Choriodecidual Infection Induces Fetal Lung Injury|
|Ryan M. McAdams1*|
|Richard P. Beyer3|
|Theo K. Bammler3|
|Federico M. Farin3|
|H. Denny Liggitt4|
|Raj P. Kapur5|
|Michael G. Gravett26|
|Craig E. Rubens167|
|Kristina M. Adams Waldorf2|
|Adam J. Ratneredit1||
1Department of Pediatrics, University of Washington, Seattle, Washington, United States of America
2Department of Obstetrics & Gynecology, University of Washington, Seattle, Washington, United States of America
3Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, United States of America
4Department of Comparative Medicine, University of Washington, Seattle, Washington, United States of America
5Department of Laboratories, Seattle Children’s, Seattle, Washington, United States of America
6Global Alliance to Prevent Prematurity & Stillbirth, Seattle, Washington, United States of America
7Division of Infectious Disease, Seattle Children’s, Seattle, Washington, United States of America
|Columbia University, United States of America
|Correspondence: * E-mail: firstname.lastname@example.org
[conflict] Competing Interests: The authors have declared that no competing interests exist.
Contributed by footnote: Conceived and designed the experiments: RMM KAW MGG CER. Performed the experiments: KAW. Analyzed the data: RPB TKB FF HDL JV RMM KAW RPK. Wrote the paper: RMM KAW JV TB RPK HDL.
Intra-amniotic inflammation is thought to play a major role in the pathogenesis of fetal lung injury, aberrant lung development and the resulting neonatal and adult chronic lung disease. ,  Bronchopulmonary dysplasia (BPD) accounts for the vast majority of chronic lung disease in infancy affecting 35% of infants weighing less than 1,500 grams.  Studies have linked elevated cytokines in the amniotic fluid with an increase in BPD and neonatal morbidity/mortality. , , ,  In surfactant-treated patients, BPD is characterized histologically by some degree of alveolar septal fibrosis, arrest in acinar development, and impaired vascular development. ,  Current therapies in the postnatal period are only minimally effective for BPD prevention ,  and the mechanisms initiating and propagating lung injury in utero remain ill-defined and difficult to study in humans because of confounding clinical variables in the care of preterm infants.
The underlying pathogenesis of BPD is thought to be due to disruption of normal growth and vasculogenesis in the saccular stage of lung development (24–38 weeks gestation), resulting in alveolar simplification from a lack of secondary alveolar septation.  Despite surfactant therapy and newer modes of mechanical ventilation, the prevalence of BPD has increased, particularly in very immature infants who may have little or no evidence of respiratory distress syndrome after birth. ,  Neonatal lung samples to study the early pathologic changes associated with BPD are extremely limited and tend to exist mainly in end-stage BPD leaving a primary role for animal models to explain the mechanisms for alveolar simplification. Possible factors include disrupted signaling between lung mesenchyme derived growth factors and distal airspace epithelium as well as disrupted endothelial–epithelial cross-talk that interferes with normal alveolar and vascular morphogenesis. ,  A critical precursor to BPD may be fetal exposure to cytokines in the amniotic fluid inducing lung injury in utero, which evolves into chronic lung injury following preterm delivery and exposure to mechanical ventilation and hyperoxia. , , , , , .
Prior studies in animal models have used ventilation after preterm delivery (sheep, baboon) or inoculation of lipopolysaccharide during pregnancy to mimic chorioamnionitis and intrauterine infection (sheep), which have produced histologic features consistent with BPD. ,  A comprehensive genomic analysis of the lung injury has not been done in these models or is not yet possible with commercial microarray platforms (e.g. sheep). These models also differ slightly from humans in terms of lung developmental stage at the time of insult, which is a possible limitation in their application to the human neonate. Most neonates who develop BPD are born during the saccular period of lung development, which spans 24 to 38 weeks gestation and reflects a critical period of morphogenesis and angiogenesis. Clusters of thin-walled saccules begin to form giving rise to the alveolar ducts. Epithelial type 2 cells and the number of small vessels increase and capillaries begin to reorganize to form an air-blood interface.  In contrast, the preterm ventilated baboon model was created in the late canalicular stage of lung development (67% of term gestation), which precedes the saccular stage and involves formation of the terminal bronchioles.  The saccular stage of lung development is not recognized in the sheep with development progressing directly to the alveolar stage much earlier in utero.  Although the histopathologic features of BPD have been described in animal models and humans, there is limited understanding of the molecular basis of impaired lung alveolarization and vascular development in the saccular stage of lung development and the relative contribution of intrauterine inflammation to the process.
To investigate early factors involved in the initiation of intrauterine inflammation and fetal lung injury, we used a chronically catheterized pregnant nonhuman primate model (pigtail macaque; Macaca nemestrina) that shares many important features with human pregnancy.  We infused Group B Streptococcus, an organism known to cause preterm birth and neonatal invasive disease, ,  into the choriodecidual space via a catheter placed between the uterine muscle and membranes (external to amniotic fluid) overlying the lower uterine segment. We performed Cesarean section four days after choriodecidual inoculation to capture early biological events associated with intrauterine infection. Bacteria did not translocate into the amniotic fluid, but did cause a cytokine-mediated pro-inflammatory response associated with fetal lung injury and in some cases, preterm labor. In this article, using microarray gene expression profiling, we describe for the first time molecular pathways that are activated and disrupted in the fetal lung during the saccular stage development associated with inflammation induced by a limited GBS choriodecidual infection.
As we previously reported, significant elevations of AF cytokines (TNF-α, IL-8, IL-1β, IL-6) were detected in GBS versus controls (p<0.05).  Lung injury was not directly caused by GBS, because GBS was undetectable by culture and PCR in the AF and fetal lungs (Table 1). Fetal plasma IL-8 was significantly higher in GBS animals versus controls and of the fetal cytokines measured it correlated best with fetal lung injury (p = 0.03).
Histopathological examination of placenta, cord and fetal membranes revealed chorioamnionitis (neutrophils in amnion and chorion) in 2/5 GBS cases and 0/5 controls (Table 1). In one of the two affected GBS placentas, active inflammation was restricted to the inoculation site. In the other, inflammation was more widely disseminated in the membranes and fetal surface of the placental disc, and was accompanied by funisitis. Neither active nor chronic (lymphohistiocytic) inflammation was observed in any of the other samples, including some GBS cases with elevated cytokine levels.
While the primary focus of this study was a genomics analysis we performed a limited correlative histologic evaluation of lung to aid in confirming these findings. Representative fetal lung sections from a GBS and saline control animal are shown in Figure 1. Lung injury was defined as an aggregate of histologic changes involving all sections from each animal including accumulation of inflammatory cells, evidence of necrosis, inflammatory related tissue thickening, collapse or other injury such as fibrin exudation or hemorrhage. There was evidence of fetal lung injury in four of the five GBS animals (lung scores = 2, 3, 3, and 4), as well as one control (lung score = 2). Inflammatory cells observed in the fetal lungs from GBS group included high numbers of neutrophils and macrophages, which is consistent with the pattern described in preterm infants at different stages of developing BPD.  In addition, there was increased staining density and thickened septa that was absent in saline controls. A lung score of 0 to 1 was considered within normal limits because mild alveolar thickening can be normal in preterm animals and a few scattered neutrophils are also expected following saline inoculation or lavage. , , .
The distribution of injury varied with severity and involved vascular, perivascular, airway and alveolar compartments. The most severe cases of fetal lung injury (fetal lung scores = 3, 3, and 4) correlated with the highest levels of amniotic fluid and fetal interleukin-8 (IL-8) levels, but not with other cytokines or prostaglandins tested (Table 1). The GBS animal with the greatest degree of fetal lung injury (lung score = 4) also developed preterm labor and had a fetal interleukin-6 (IL-6) level of 11.3 pg/ml, which is diagnostic of the fetal systemic inflammatory response syndrome (FIRS) in humans.  In the other three GBS animals with fetal lung injury, the fetal IL-6 level (2.6, 3.1, 7.5 pg/ml) was below the threshold for FIRS. Fetal plasma IL-1β was undetectable in all but one animal and fetal plasma tumor necrosis factor-alpha (TNF-α) was undetectable in all but two animals. In one control animal with an elevated fetal lung injury score (lung score = 2), there was an infarction of a lung tip that appeared histologically very different from the controls and GBS lungs. In this case, hemorrhage was the predominant finding and thought to have occurred peri-mortem.
After choriodecidual GBS exposure, there was differential expression of 707 out of 52,865 probesets (428 up- and 279 downregulated) in the fetal lung at least 1.5 fold (p<0.05). When probesets were matched to genes and duplicates removed, there was differential expression of 335 out of 19,571 genes (232 up- and 103 downregulated). A subset of these genes is shown in Table 2 and the entire set (707 probesets) and a heatmap (335 genes) is available in supplementary material (Table S1, Figure S1). Examples of genes significantly upregulated included indoleamine 2,3-dioxygenase 1 (IDO1), serpin peptidase inhibitor clade A member 3 (SERP3; also called alpha-1 antiproteinase, antitrypsin), chemokine (C-C motif) ligand 3 (CCL3), matrix metalloproteinase 1 (MMP1), IL-1β, and IL-8. Genes significantly downregulated by choriodecidual GBS exposure included similar to aldo-keto reductase family 1 member B10 (AKR1B10), which is implicated in the process of lung septation (see discussion) and adenylosuccinate synthase (ADSS). The magnitude of change ranged from 3.0 log2 fold for upregulated and 3.5 log2 fold for downregulated genes.
There are eight surfactant protein probesets on the Affymetrix Rhesus Macaque Array, but only 5 of the probesets were annotated in the single gene analysis by the Affymetrix software. When the IPA software was used to annotate the genes using their proprietary database, more surfactant proteins (SFTP) were identified. None of the eight probesets demonstrated significant differential regulation in the single gene analysis, but SFTPA1 and SFTPA2 were the most differentially expressed of the group (log2 fold 0.71 and 0.73, respectively).
Gene sets and pathways with concordant changes in expression were identified using GSA. Gene sets enriched after GBS exposure are shown in Table 3 with a complete listing provided in supplementary material (Table S2). Heat maps of select gene sets associated with inflammation, angiogenesis, and cellular growth are shown in Figure 2. Upregulated gene sets in the GBS group were frequently related to activation of an innate and adaptive immune response including positive regulation of immune response, neutrophil chemotaxis, positive regulation of IL-8, regulation of T cell activation, positive regulation of adaptive immune response, dendritic cell chemotaxis, and antigen processing and presentation of exogenous peptide antigen via Major Histocompatibility Complex (MHC) class II. Other pathways upregulated in the GBS group included pyrimidine base metabolic process, leukotriene metabolic process, cell-cell signaling, pyrimidine nucleoside salvage, and negative regulation of nitric oxide synthase activity. Gene sets downregulated following GBS exposure were frequently related to morphogenesis, cellular growth and structure (e.g. cardiac muscle tissue development, luteinization, Notch receptor processing) and angiogenesis (e.g. sprouting angiogenesis, blood vessel maturation, vasculogenesis). These gene sets are shown in Table 4 with a full listing in supplementary material (Table S3).
IPA mapped 36,617 probesets out of the 52,779 probesets on the Affymetrix Macaca mulatta microarray. The top five canonical pathways identified by IPA analysis were the antigen presentation pathway, dendritic cell maturation, triggering receptor expressed on myeloid cells 1 (TREM1) signaling, allograft rejection signaling, and communication between innate and adaptive immune cells (Table 5). IPA analysis also has the capability to predict activation states of transcriptional regulators based on the activation or suppression of downstream genes. The top five transcription factors predicted to be associated with the changes in genes expression were NF-kappa B (NF-κB), signal transducer and activator of transcription 3 (STAT3), STAT1, CCAAT/enhancer-binding protein alpha (CEBPA), and spleen focus forming virus (SFFV) proviral integration oncogene (SPI1); all were predicted to be in the activated state. IPA diagrams of the Gene Ontology gene set neutrophil chemotaxis and NF-κB are shown in Figure 3.
We identified 16 genes of interest from the microarray dataset, which we analyzed by quantitative RT-PCR. We directly compared levels of gene expression obtained with amplified RNA samples using GAPDH expression as a control for input cDNA. Overall agreement between the mRNA generated microarray data and the quantitative RT-PCR data was approximately 94% with only one discordant gene out of 16 tested [human kallikrein 7 (HK7); Figure 4]. There was a significant difference in RT-PCR results between GBS and controls for AKR1B10, wingless-type MMTV integration site family member 3 (WNT3), angiopoietin 1 (ANGPT1), serpina 3 (SERP3), and MMP1 (all p<0.05).
Studying biological events that occur prior to birth is extraordinarily difficult for ethical reasons and also because lung development in other animal models does not necessarily emulate the human fetus. We have overcome these challenges and present the first comprehensive genomics study of cytokine-induced fetal lung injury in a nonhuman primate model that shares many key features with human pregnancy and lung development.  A key feature of this model is the amniotic fluid contained elevated cytokine levels without detectable bacteria suggesting that the fetal lung injury may occur silently through the action of inflammatory mediators many days before the development of preterm labor.  The current study expands our understanding of the gene pathways affected by in utero inflammation that may be precursor pathways important for the prevention of alveolar growth arrest and microvascular disruption present in infants that develop BPD.
Our data suggest a conceptual model shown in Figure 5, which extends the original hypothesis of Yoon et al in 1997 that began to link amniotic fluid inflammation with fetal lung injury.  First, we hypothesize that vaginal bacteria traffic upwards through the cervix and into the choriodecidual space, which lies between the fetal membranes and the uterus (external to the amniotic sac). A pro-inflammatory cytokine response ensues, which may or may not trigger preterm labor depending on the severity. Cytokines and other inflammatory mediators produced in the choriodecidual space begin to diffuse into the AF. The fetal lungs are in direct contact with the amniotic fluid due to normal swallowing in utero, which has been reported as early as 11 weeks.  When pro-inflammatory cytokines from the AF come into contact with the fetal lungs, an innate immune response is initiated in the fetal lungs with subsequent recruitment of neutrophils and macrophages. ,  Inflammation results with the degree likely related to the intensity, duration, and developmental timing of the cytokine exposure. Pulmonary gene expression related to the innate and adaptive immune response increases while expression related to angiogenesis, morphogenesis, and cellular development decreases. This inflammation may set the stage for further lung injury and BPD if preterm delivery occurs with subsequent lung injury by mechanical ventilation and hyperoxia.
Our data is consistent with many prior studies implicating a role for several inflammatory mediators (IL-1β, TNF-α, IL-6, IL-8) in BPD development, which were significantly elevated in the AF of our model. , , , ,  Although not specific for BPD, elevated IL-6 and IL-8 precede neutrophil infiltration in tracheal aspirates from preterm infants who develop BPD.  Innate immune responses, neutrophil chemotaxis, regulation of IL-8, and leukotriene metabolism were associated with fetal lung injury and featured prominently in our GSA. Interestingly, elevated leukotriene levels in tracheal lavage fluid are thought to be related to the bronchospasm associated with BPD.  Consistent with our model, increased neutrophils and macrophages in the pulmonary effluent of neonates with BPD may occur even in the absence of bacterial colonization. ,  The transcriptional activators, NF-κB and STAT3, were predicted to be activated by IPA and are known to play a role in the innate immune response. Downstream genes activated by NF-κB that are associated with BPD development include IL-8 and MMP-1 and MMP-9. STAT3 has been previously implicated in fetal lung injury in the setting of chorioamnionitis and is identified as a potential target for regulating the pulmonary inflammatory response. ,  In addition to innate immune responses, the adaptive immune response gene sets (e.g. dendritic cell chemotaxis, regulation of T cell activation) and genes involved in dendritic cell activation (e.g. CCR7) were significantly upregulated in the analysis. These results are consistent with findings of pulmonary recruitment of dendritic cells in human exposed to antenatal infection and ventilation who develop BPD.  Dendritic cells, which express a wide array of pro- and anti-angiogenic mediators, are closely associated with the pulmonary microvasculature and may contribute to BPD-associated dysangiogenesis. , .
Many of the downregulated genes or gene sets (i.e. Gene Ontology categories associated with specific biological processes) have putative or known roles in lung development, growth and structural integrity. AKR1B10 catalyzes the essential first step in the retinoic acid synthesis pathway, which increases lung septation (−1.9 log2 fold). , ,  AKR1B10 is also important for cell survival and when silenced by small-interfering RNA resulted in elevated intracellular lipid peroxides and caspase-3-mediated apoptosis.  GSA identified many of the following downregulated genes in gene pathways for luteinization and cardiac muscle tissue development that are known to be involved in lung morphogenesis. Both Wnt5a and its receptor Frizzled 4 (FZD4) play an important role in morphogenesis of the distal lung. ,  Deficiency of SMAD3, a major signal transducer in the transforming growth factor-beta (TGF-β) pathway, impairs neonatal lung alveolarization and peripheral lung cell proliferation based in murine studies.  Platelet derived growth factor receptor, alpha polypeptide (PDGFRA) is expressed by bronchiolar smooth muscle progenitors and might impair mesodermal development if downregulated.  T-box (TBX) transcription factors, such as TBX2 in the cardiac muscle tissue development pathway, have been implicated in developing lung mesoderm.  Finally, phosphatase and tensin homolog (PTEN) has been shown to be essential for normal lung morphogenesis and when deleted in mice resulted in impaired branching morphogenesis and distal alveolar epithelial cell differentiation. .
Other downregulated genes and gene sets were associated with angiogenesis and vascular dysfunction. ANGPT1 is the primary agonist of the tyrosine kinase receptor Tie 2 (tyrosine kinase with immunoglobulin and EGF-like domains), which is restricted to endothelial cell expression. , ,  Cord blood plasma levels of ANGPT1 in preterm infants who subsequently develop BPD are significantly lower than those without BPD.  G protein-coupled receptor 124 (GPR124) is thought to play a role in regulating sprouting, migration, and developmental expression of the blood-brain barrier and is also expressed in embryonic epithelium of lung.  Cadherin 13 (CDH13), an atypical glycosylphosphatidylinositol (GPI)-anchored member of the cadherin superfamily widely expressed in the cardiovascular system, is involved in tumor angiogenesis and promotes proliferation in vascular cells and angiogenesis via activation of the PI3K/Akt/mTOR signaling pathway when overexpressed and ligated. , , ,  Notch signaling was downregulated in the GSA, which is thought to play a primary role in selection of Clara cell fate and arterial vascular smooth muscle cell recruitment , , ; Notch signaling also negatively regulates vascular endothelial growth factor (VEGF)-induced angiogenesis and is thought to suppress aberrant vascular branching morphogenesis.  Our data also demonstrated a significant downregulation of genes in the GBS group associated with regulation of nitric oxide synthase (NOS). In the preterm lamb lung, antenatal exposure to intra-amniotic endotoxin is associated with decreased postnatal endothelial NOS (eNOS) expression measured at 2–4 days of age followed by vascular remodeling changes in small pulmonary arteries demonstrated by medial smooth muscle hypertrophy and increased adventitial fibrosis. .
The strength of our study lies in the similarities in lung development and immune function between the nonhuman primate and human neonate. Pulmonary morphologic and immune features in our model also emulate that in humans, but differ from many other species.  Both humans and nonhuman primates lack pulmonary intravascular macrophages present in the lungs of many species (e.g. sheep, cattle, pigs) which tend to concentrate toxins and bacteria in the lungs. In contrast, humans and nonhuman primates localize bacteria and toxins in the liver and spleen, which makes their lungs less susceptible to injury than other species. ,  There are also many similarities to human pregnancy including a singleton fetus with a long gestational period, hemomonochorial placentation, and sensitivity to pathogens (e.g. lipopolysaccharide). Maternal-fetal inflammatory responses induced by infection and parturition also emulate that in humans, but differ significantly in other animal models. Many mammalian models in which lung development has been studied (e.g. sheep) are also in the alveolar stage of lung development, which is more advanced at the time of a preterm birth than in human preterm neonates (saccular) who go on to develop BPD. The elevated AF cytokine levels despite negative AF culture results seen in our model also appears to replicate the clinical condition in humans seen in up to 25% of preterm labor cases with elevated amniotic fluid IL-6 and a negative culture and/or PCR. , ,  Therefore, our model may reflect a common biological event of pro-inflammatory cytokine signaling induced by many different pathogens in the choriodecidual space and is not restricted specifically to GBS.
A limitation of our study is the lack of lung morphometry, but the time course from infection to delivery was fairly short (4 days) and differences may not yet have become apparent. Lung injury in this model was originally unexpected and the fetal lung was not preserved in such a way to accurately measure lung morphometry later. Another limitation, as well as study strength, is that our results reflect an early or limited choriodecidual infection. We may have interrupted pathways leading to further fetal lung injury, maturation, or possibly repair with further time in utero. The acute histologic changes seen in the GBS exposed animals lungs, including accumulation of inflammatory cells, interstitial wall tissue thickening, and fibrin exudation or hemorrhage, may be precursor findings that subsequently develop into the histopathologic findings of alveolar simplification and enlargement characteristic of the new BPD after premature infants are exposed to mechanical ventilation, hyperoxia, and/or sepsis.  The risk for developing BPD in association with histologic chorioamnionitis increases in infants who are exposed to mechanical ventilation postnatally.  Since our model focused on early in utero time points, it is not known if the histopathologic findings in the GBS exposed animals would eventually develop BPD-like features if exposed to other postnatal insults associated with ventilation; however, our gene expression findings suggest this possibility. Therefore, future studies in our model are needed to determine if the fetal lung injury associated with elevated AF pro-inflammatory cytokines requires subsequent postnatal injury (e.g., mechanical ventilation or sepsis) for BPD to develop. The timing, degree, and duration of exposures and events producing lung injury in utero and ex utero may influence the ultimate pulmonary phenotype of preterm infants at risk for BPD. Our sample size is also modest, which is typical of nonhuman primate studies and necessary for ethical reasons and conservation. Finally, not all the probe sets on the Affymetrix chip are annotated and some differentially regulated genes could not be identified.
The microarray analysis reported in this study measured expression of thousands of genes in a limited number of biological replicates. A concern with this experimental design is a Type I (“false positive”) or Type II (“false negative”) error when assessing the statistical significance of expression changes of single genes. We minimized this concern with the following strategies. First, the samples that were used for microarray analysis were carefully phenotyped, i.e. lung injury was defined as an aggregate of histologic changes including accumulation of inflammatory cells, evidence of necrosis, inflammatory related tissue thickening, collapse or other injury such as fibrin exudation or hemorrhage. We also used a 1.5-fold expression change criteria in addition to a p-value cut-off (p<0.05) to define differential gene expression. By using a combination of a fold-change and p-value criteria, Type I and II errors are decreased. In addition to carrying out single gene analysis, we also carried out Gene Set Analysis and Ingenuity Pathway Analysis. Both of these methods assess the statistical significance of pre-defined sets of genes/pathways as a whole, rather than single genes. Therefore, these methods are less prone to Type I or II errors derived from single genes. Finally, we validated a subset of genes that microarray analysis identified as differentially expressed with quantitative RT-PCR analysis and found a 94% agreement between these two independent methods. Given that it is cost-prohibitive to increase the number of animals (biological replicates) in this study, the aforementioned approaches minimize Type I and II errors as much as it is practically possible.
Our work confirms many of the pathways reported in later stages of lung development from ventilated preterm neonates , , ,  and alveolar stage models of fetal lung injury. , , ,  Our study extends this work with the first comprehensive genomic analysis of early in utero lung injury in the saccular stage of lung development. Molecular pathways reveal a significant disruption in angiogenesis and morphogenesis with upregulation of both innate and adaptive immune pathways. The finding that significant fetal lung injury occurred silently before preterm labor is also novel and quite sobering for the development of preventive strategies. Our data suggest that molecular pathways leading to BPD may originate in utero and precede delivery by several days or longer before a clinically recognizable event like preterm labor. Future studies to analyze changes in the fetal lung proteome and microRNAs will be important to complement this work in understanding the pathogenesis of in utero fetal lung injury. The nonhuman primate may be uniquely suited for the future study of therapies during pregnancy to limit in utero lung injury and prevent the resulting aberrant lung development.
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Research Council and the Weatherall report, “The use of non-human primates in research”. The protocol was approved by the Institutional Animal Care Use Committee of the University of Washington (Permit Number: 4165-01). All surgery was performed under general anesthesia and all efforts were made to minimize suffering.
Ten chronically catheterized pregnant monkeys (Macaca nemestrina) at 118–125 days gestation (term = 172 days) received one of two experimental treatments: 1) choriodecidual and intra-amniotic saline infusions (n = 5), or 2) GBS choriodecidual inoculation (n = 5). In two saline controls, fetal samples were not collected due to either an inability to place the fetal catheter during initial surgery or clotting of the fetal catheter. This resulted in three fetal cytokine analyses in the saline group. In one GBS case, technical problems led to only intermittent data collection and so the remaining uterine activity data was excluded for this animal. The cytokine analyses were previously published and are presented to give context to the genomics analyses. .
In our model, pregnant pigtail macaques were time-mated and fetal age determined using early ultrasound. Temperature in the animal quarters was maintained at 72–82 degrees Fahrenheit. Animals were fed a commercial monkey chow, supplemented daily with fruits and vegetables and drinking water was available at all times. The tethered chronic catheter preparation was used for all in vivo experiments and is a major breakthrough in studying maternal-fetal immunologic responses. ,  The animal was first conditioned to a nylon jacket/tether system for several weeks before surgery, which allowed free movement within the cage, but protected the catheters. On day 118–125 of pregnancy (term = 172 days) catheters were surgically implanted via laparotomy into the maternal femoral artery and vein, fetal internal jugular vein, amniotic cavity, and choriodecidual interface in the lower uterine segment (between uterine muscle and fetal membranes, external to amniotic fluid). Fetal ECG electrodes and a maternal temperature probe were also implanted. Post-operative analgesia was provided by a 25 microgram fentanyl patch applied the day prior to surgery, in addition to postoperative indomethacin. After 48 hours, the animals appeared to have recovered from surgery based on a return to baseline for activity, appetite, and bowel function.
After surgery, the animal was placed in the jacket and tether with the catheters/electrodes tracked through the tether system. Cefazolin and terbutaline sulfate were administered to reduce postoperative infection risk and uterine activity. Both cefazolin and terbutaline were stopped at least 72 hours before experimental start (∼13 half-lives for terbutaline, 40 half-lives for cefazolin, >97% of both drugs eliminated), which represented approximately a 7–10 day period of postoperative terbutaline administration. Cefazolin 1 gram was administered intravenously each day in saline controls to minimize chances of a catheter-related infection. Experiments began approximately two weeks after catheterization surgery to allow recovery (∼30–31 weeks human gestation). At our center, term gestation in the non-instrumented pigtail macaque population averages 172 days.
After cesarean section, fetuses were euthanized by barbiturate overdose followed by exsanguination and fetal necropsy with tissue fixation in 10% neutral buffered formalin. Complete gross and histopathologic examination was performed on infants and placentas. For histologic examination two to three randomly selected fixed fetal lung tissues were embedded in paraffin and sections stained with hematoxylin and eosin (H&E), Masson’s trichrome or specific esterase (Leder stain) using standard protocols. Leder staining was performed using the Naphthol AS-D Chloroacetate Specific Esterase Kit (Sigma-Aldrich, St. Louis, MO) per manufacturer’s instructions. Masson’s trichrome staining was performed to differentially highlight the presence of connective tissue by a standard method involving serial incubations in Bouin’s fixative, Weigert’s iron hematoxylin, Biebrich scarlet-acid fuchsin, phosphomolybdic-phosphotungstic acid and aniline blue. The placenta was examined by a board-certified pediatric pathologist (R.P.K.) and fetal lungs examined by a board-certified veterinary pathologist (H.D.L.) with each pathologist blinded to group assignment. H&E-stained full-thickness sections of placental disc, umbilical cord, and a fetal membrane roll were examined from each case to exclude inflammation, necrosis, fetal vascular thrombosis, or other histopathological findings. Chorioamnionitis was diagnosed when neutrophils were identified in the chorion and/or amnion. Funisitis denoted neutrophils in the umbilical vessels and/or surrounding connective tissue. Lung histologic sections were evaluated and scored, as previously described, using a semi-quantitative scale.  Components were scored on a scale of 0–4 (0 = normal) for inflammatory cells, necrosis, and inflammation including tissue thickening, collapse or other injury (e.g. fibrin exudation). Lung compartments scored were (1) vascular/perivascular; (2) bronchial/peribronchial; (3) alveolar wall; and (4) trichrome stain intensity positivity. Mononuclear inflammatory cells and neutrophils (Leder stain) within alveolar spaces were counted (5 random 40X fields). An overall severity score was generated. A lung score of 0 to 1 was considered within normal limits as a few neutrophils are expected following saline inoculation and mild alveolar thickening is normal in some preterm animals.
Immunohistochemistry staining for CD68 was performed using a mouse monoclonal CD68 primary antibody (1∶1,000 dilution, Clone: KP1, MS-397-P1 (Thermo Fisher Scientific, Waltham, MA) a normal mouse IgG isotype control (1∶200 dilution, Vector Labs, I-2000), and a spleen control from M. nemestrina. First, the slides were baked for 30 minutes at 60°C and deparaffinized on the Leica Bond Automated Immunostainer (Leica Microsystems, Buffalo Grove, IL). Antigen retrieval was performed by placing slides in HIER Citrate Buffer for 10 minutes at 100°C. Blocking consisted of Leica Bond Peroxide block for 5 minutes at room temperature (RT) and then 10% Normal Goat Serum in PBS for 10 minutes at RT. Either the primary antibody (mouse anti-CD68, 1∶1,000 dilution, 0.2 µg/mL) or mouse isotype IgG control (1∶200 dilution, 1 µg/mL) in Leica Primary antibody diluent was applied for 30 minutes at RT. Leica Bond post primary was then applied for 8 minutes at RT. Antibody complexes were visualized using Leica Bond Polymer DAB Refine for 8 minutes at RT and then Leica Bond Mixed Refine (DAB) detection 2X for 10 minutes at RT. Tissues were counterstained with hematoxylin counterstain for 10 second followed by two rinses in H20. Unless otherwise specified all reagents were obtained from Leica Microsystems.
To study genetic pathways in M. nemestrina, we used the Affymetrix Rhesus Macaque Array (GeneChip® Rhesus Macaque Genome Array, Affymetrix, Santa Clara, CA), which allows interrogation of 47,000 M. mulatta transcripts and provides comprehensive transcriptome coverage. Genetic differences between M. mulatta and M. nemestrina are predicted to be <1%, which is consistent with our published data.  RNA extraction was performed by the CHDD Genomics Core Laboratory followed by the manufacturer’s protocols using the GeneChip platform by Affymetrix. Briefly, these methods include the synthesis of first- and second-strand cDNAs, the purification of double-stranded cDNA, the synthesis of cRNA by in vitro transcription (IVT), the recovery and quantitation of biotin-labeled cRNA, the fragmentation of this cRNA and subsequent hybridization to the microarray slide, the post-hybridization washings, and the detection of the hybridized cRNAs using a streptavidin-coupled fluorescent dye. Hybridized Affymetrix arrays were scanned with an Affymetrix GeneChip® 3000 fluorescent scanner. Image generation and feature extraction was performed using Affymetrix GeneChip Command Console Software.
The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession number GSE39029 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39029). Analysis of the microarray data focused first on differential expression of single genes. Raw microarray data was pre-processed and analyzed with Bioconductor (http://www.bioconductor.org/).  Several quality control steps were carried out to insure that the data was of high quality: 1) visual inspection of the GCOS DAT chip images, 2) visual inspection of the chip pseudo-images generated by the Bioconductor affyPLM package, 3) generation of percent present calls and average background signals with the Bioconductor simpleaffy package, 4) generation and inspection histograms of raw signal intensities, and 5) generation and comparison of the Relative Log Expression and Normalized Unscaled Standard Errors using the Bioconductor affyPLM package. The data was normalized with the Bioconductor GeneChip Robust Multiarray Averaging (RMA) package.  From the normalized data, genes with significant evidence for differential expression were identified using the Limma package in Bioconductor.  P-values were calculated with a modified t-test in conjunction with an empirical Bayes method to moderate the standard errors of the estimated log-fold changes. P-values were adjusted for multiplicity with the Bioconductor package qvalue, which allows for selecting statistically significant genes while controlling the estimated false discovery rate. .
Next, the data was analyzed using GSA in order to investigate categories of genes. ,  GSA assesses the statistical significance of pre-defined gene sets/pathways as a whole rather than of single genes, which allows for the identification of modest but concordant changes in expression of individual genes that may be missed by single gene analysis. GSA software is available as R code (http://www.broad.mit.edu/GSA/). ,  GSA considers all the genes in the experiment and allows for the identification of gene sets with strong cross-correlation by boosting the signal-to-noise ratio, which makes it possible to detect modest changes in gene expression. In GSA, the p-values that are calculated to test the null hypothesis are based on permutations of the sample labels. We used four gene set databases for the GSA: three from Gene Ontology  (Biological Process, Molecular Function, and Cellular Component), and the functional C2 gene set from the Molecular Signature Database  (http://www.broad.mit.edu/GSA/msigdb/msigdb_index.html).
We used the Ingenuity Pathway Analysis (IPA) software (Ingenuity® Systems, www.ingenuity.com) to discover pathways and transcriptional networks in the gene expression microarray data. Our data set containing gene identifiers and corresponding expression changes between the experimental groups and p-values was uploaded into the IPA application. Each identifier was mapped to its corresponding object in the Ingenuity® Knowledge Base. The Functional Analysis identified the biological functions and/or diseases that were most significant to the data set. Genes from the data set with more than 1.5-fold differential expression (up/down regulation) and p<0.05 that were associated with biological functions and/or diseases in the Ingenuity Knowledge Base were considered for the analysis. The categories “Top Canonical Pathways” and “Top Transcription Factors” were primarily used in this analysis. Right-tailed Fisher’s exact test was used to calculate a p-value determining the probability that each biological function and/or disease assigned to that data set is due to chance alone. The IPA Path Designer Graphical Representation was used to generate figures. Molecules are represented as nodes, and the biological relationship between two nodes is represented as an edge (line). All edges are supported by at least one reference from the literature, from a textbook, or from canonical information stored in the Ingenuity Knowledge Base. Human, mouse, and rat orthologs of a gene are stored as separate objects in the Ingenuity Knowledge Base, but are represented as a single node in the network. The intensity of the node color indicates the degree of up- (red) or down- (green) regulation. Nodes are displayed using various shapes that represent the functional class of the gene product. Edges are displayed with various labels that describe the nature of the relationship between the nodes (see figure legends for details). IPA also allows prediction of the activation or inhibition of transcription factors involved in the gene expression patterns seen in our study.
Comparison of mRNA expression in the fetal lung by microarray analysis in GBS and saline groups displaying the relative Cy3/Cy5 ratios. mRNA expression is displayed as either higher (red) or lower (green) in GBS compared to saline controls.
Click here for additional data file (pone.0046863.s001.png)
All probe sets in the single gene analysis differentially expressed at the 1.5-fold level, p<0.05.
Click here for additional data file (pone.0046863.s002.docx)
Gene sets upregulated after GBS exposure relative to the control group.
Click here for additional data file (pone.0046863.s003.docx)
Gene sets downregulated after GBS exposure relative to the control group.
Click here for additional data file (pone.0046863.s004.docx)
We gratefully acknowledge the technical assistance of Jennifer Summers in preparing the figures.
|1.||Lee J,, Oh KJ,, Yang HJ,, Park JS,, Romero R,, et al. (Year: 2009) The importance of intra-amniotic inflammation in the subsequent development of atypical chronic lung disease. J Matern Fetal Neonatal Med22: 917–92319718578|
|2.||Kramer BW,, Kallapur S,, Newnham J,, Jobe AH, (Year: 2009) Prenatal inflammation and lung development. Semin Fetal Neonatal Med14: 2–718845493|
|3.||Stroustrup A,, Trasande L, (Year: 2010) Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993–2006. Pediatrics126: 291–29720643728|
|4.||Yoon BH,, Romero R,, Jun JK,, Park KH,, Park JD,, et al. (Year: 1997) Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol177: 825–8309369827|
|5.||Ghezzi F,, Gomez R,, Romero R,, Yoon BH,, Edwin SS,, et al. (Year: 1998) Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol78: 5–109605441|
|6.||Husain AN,, Siddiqui NH,, Stocker JT, (Year: 1998) Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol29: 710–7179670828|
|7.||Gien J,, Kinsella JP, (Year: 2011) Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr23: 305–31321494147|
|8.||Fok TF, (Year: 2009) Adjunctive pharmacotherapy in neonates with respiratory failure. Semin Fetal Neonatal Med14: 49–5518851933|
|9.||Thomas W,, Speer CP, (Year: 2008) Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia–what is the evidence?Neonatology94: 150–15918679037|
|10.||Ahlfeld SK,, Conway SJ, (Year: 2012) Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol94: 3–1522125178|
|11.||Philip AG, (Year: 2012) Bronchopulmonary Dysplasia: Then and Now. Neonatology102: 1–822354063|
|12.||Smith VC,, Zupancic JA,, McCormick MC,, Croen LA,, Greene J,, et al. (Year: 2005) Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr146: 469–47315812448|
|13.||Speer CP, (Year: 2003) Inflammation and bronchopulmonary dysplasia. Semin Neonatol8: 29–3812667828|
|14.||Jobe AH, (Year: 2011) The new bronchopulmonary dysplasia. Curr Opin Pediatr23: 167–17221169836|
|15.||Coalson JJ,, Winter VT,, Siler-Khodr T,, Yoder BA, (Year: 1999) Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med160: 1333–134610508826|
|16.||Albertine KH,, Jones GP,, Starcher BC,, Bohnsack JF,, Davis PL,, et al. (Year: 1999) Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med159: 945–95810051278|
|17.||Thompson A,, Bhandari V, (Year: 2008) Pulmonary Biomarkers of Bronchopulmonary Dysplasia. Biomark Insights3: 361–37319430584|
|18.||Alcorn DG,, Adamson TM,, Maloney JE,, Robinson PM, (Year: 1981) A morphologic and morphometric analysis of fetal lung development in the sheep. Anat Rec201: 655–6677340570|
|19.||Adams Waldorf KM,, Rubens CE,, Gravett MG, (Year: 2011) Use of nonhuman primate models to investigate mechanisms of infection-associated preterm birth. BJOG118: 136–14421040390|
|20.||Larsen JW, Sever JL (2008) Group B Streptococcus and pregnancy: a review. Am J Obstet Gynecol 198: 440–448; discussion 448–450.|
|21.||Melin P, (Year: 2011) Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect17: 1294–130321672083|
|22.||Adams Waldorf KM,, Gravett MG,, McAdams RM,, Paolella LJ,, Gough GM,, et al. (Year: 2011) Choriodecidual Group B Streptococcal Inoculation Induces Fetal Lung Injury without Intra-Amniotic Infection and Preterm Labor in Macaca nemestrina. PLoS One6: e2897222216148|
|23.||Speer CP, (Year: 2006) Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med11: 354–36216702036|
|24.||Damiano VV,, Cohen A,, Tsang AL,, Batra G,, Petersen R, (Year: 1980) A morphologic study of the influx of neutrophils into dog lung alveoli after lavage with sterile saline. Am J Pathol100: 349–3647406015|
|25.||Ettensohn DB,, Jankowski MJ,, Redondo AA,, Duncan PG, (Year: 1988) Bronchoalveolar lavage in the normal volunteer subject. 2. Safety and results of repeated BAL, and use in the assessment of intrasubject variability. Chest94: 281–2853396404|
|26.||Kazmierowski JA,, Fauci AS,, Reynolds HY, (Year: 1976) Characterization of lymphocytes in bronchial lavage fluid from monkeys. J Immunol116: 615–618815431|
|27.||Romero R,, Gomez R,, Ghezzi F,, Yoon BH,, Mazor M,, et al. (Year: 1998) A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol179: 186–1939704786|
|28.||Diamant NE, (Year: 1985) Development of esophageal function. Am Rev Respir Dis131: S29–324003905|
|29.||Pollack JA,, Moise KJ Jr,, Tyson WR,, Galan HL, (Year: 2003) The role of fetal breathing motions compared with gasping motions in pulmonary airway uptake of intra-amniotic iron dextran. Am J Obstet Gynecol189: 958–96214586334|
|30.||Galan HL,, Tennant LB,, Marsh DR,, Creasy RK, (Year: 1997) Paralysis of the preterm rabbit fetus inhibits the pulmonary uptake of intraamniotic iron dextran. Am J Obstet Gynecol177: 42–499240581|
|31.||Bry K,, Whitsett JA,, Lappalainen U, (Year: 2007) IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol36: 32–4216888287|
|32.||Munshi UK,, Niu JO,, Siddiq MM,, Parton LA, (Year: 1997) Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol24: 331–3369407566|
|33.||Paananen R, Husa AK, Vuolteenaho R, Herva R, Kaukola T, et al. . (2009) Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 154: 39–43 e33.|
|34.||Kotecha S,, Chan B,, Azam N,, Silverman M,, Shaw RJ, (Year: 1995) Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed72: F90–967712280|
|35.||Mirro R,, Armstead W,, Leffler C, (Year: 1990) Increased airway leukotriene levels in infants with severe bronchopulmonary dysplasia. Am J Dis Child144: 160–1612154089|
|36.||Ogden BE,, Murphy SA,, Saunders GC,, Pathak D,, Johnson JD, (Year: 1984) Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis130: 817–8216333839|
|37.||Merritt TA,, Cochrane CG,, Holcomb K,, Bohl B,, Hallman M,, et al. (Year: 1983) Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest72: 656–6666603478|
|38.||Kunzmann S,, Collins JJ,, Yang Y,, Uhlig S,, Kallapur SG,, et al. (Year: 2011) Antenatal inflammation reduces expression of caveolin-1 and influences multiple signaling pathways in preterm fetal lungs. Am J Respir Cell Mol Biol45: 969–97621562314|
|39.||Gao H,, Ward PA, (Year: 2007) STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses. Expert Opin Ther Targets11: 869–88017614756|
|40.||De Paepe ME, Hanley LC, Lacourse Z, Pasquariello T, Mao Q (2010) Pulmonary dendritic cells in lungs of preterm infants: Neglected participants in bronchopulmonary dysplasia? Pediatr Dev Pathol.|
|41.||Sozzani S,, Rusnati M,, Riboldi E,, Mitola S,, Presta M, (Year: 2007) Dendritic cell-endothelial cell cross-talk in angiogenesis. Trends Immunol28: 385–39217692569|
|42.||Gallego O,, Belyaeva OV,, Porte S,, Ruiz FX,, Stetsenko AV,, et al. (Year: 2006) Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids. Biochem J399: 101–10916787387|
|43.||Crosas B,, Hyndman DJ,, Gallego O,, Martras S,, Pares X,, et al. (Year: 2003) Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J373: 973–97912732097|
|44.||Bry K,, Lappalainen U, (Year: 2006) Pathogenesis of bronchopulmonary dysplasia: the role of interleukin 1beta in the regulation of inflammation-mediated pulmonary retinoic acid pathways in transgenic mice. Semin Perinatol30: 121–12816813970|
|45.||Wang C,, Yan R,, Luo D,, Watabe K,, Liao DF,, et al. (Year: 2009) Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J Biol Chem284: 26742–2674819643728|
|46.||Pongracz JE,, Stockley RA, (Year: 2006) Wnt signalling in lung development and diseases. Respir Res7: 1516438732|
|47.||Li C,, Xiao J,, Hormi K,, Borok Z,, Minoo P, (Year: 2002) Wnt5a participates in distal lung morphogenesis. Dev Biol248: 68–8112142021|
|48.||Chen H,, Sun J,, Buckley S,, Chen C,, Warburton D,, et al. (Year: 2005) Abnormal mouse lung alveolarization caused by Smad3 deficiency is a developmental antecedent of centrilobular emphysema. Am J Physiol Lung Cell Mol Physiol288: L683–69115591413|
|49.||Morrisey EE,, Hogan BL, (Year: 2010) Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell18: 8–2320152174|
|50.||Chapman DL,, Garvey N,, Hancock S,, Alexiou M,, Agulnik SI,, et al. (Year: 1996) Expression of the T-box family genes, Tbx1–Tbx5, during early mouse development. Dev Dyn206: 379–3908853987|
|51.||Yanagi S,, Kishimoto H,, Kawahara K,, Sasaki T,, Sasaki M,, et al. (Year: 2007) Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest117: 2929–294017909629|
|52.||Sato TN,, Tozawa Y,, Deutsch U,, Wolburg-Buchholz K,, Fujiwara Y,, et al. (Year: 1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature376: 70–747596437|
|53.||Thurston G,, Suri C,, Smith K,, McClain J,, Sato TN,, et al. (Year: 1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science286: 2511–251410617467|
|54.||Davis S,, Aldrich TH,, Jones PF,, Acheson A,, Compton DL,, et al. (Year: 1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell87: 1161–11698980223|
|55.||Mohamed WA,, Niyazy WH,, Mahfouz AA, (Year: 2011) Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. J Trop Pediatr57: 385–38821131270|
|56.||Kuhnert F,, Mancuso MR,, Shamloo A,, Wang HT,, Choksi V,, et al. (Year: 2010) Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science330: 985–98921071672|
|57.||Hebbard LW,, Garlatti M,, Young LJ,, Cardiff RD,, Oshima RG,, et al. (Year: 2008) T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res68: 1407–141618316604|
|58.||Joshi MB,, Philippova M,, Ivanov D,, Allenspach R,, Erne P,, et al. (Year: 2005) T-cadherin protects endothelial cells from oxidative stress-induced apoptosis. FASEB J19: 1737–173916099944|
|59.||Philippova M,, Banfi A,, Ivanov D,, Gianni-Barrera R,, Allenspach R,, et al. (Year: 2006) Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol26: 2222–223016873731|
|60.||Ivanov D,, Philippova M,, Allenspach R,, Erne P,, Resink T, (Year: 2004) T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res64: 132–14315364621|
|61.||Morimoto M,, Liu Z,, Cheng HT,, Winters N,, Bader D,, et al. (Year: 2010) Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci123: 213–22420048339|
|62.||Tsao PN,, Vasconcelos M,, Izvolsky KI,, Qian J,, Lu J,, et al. (Year: 2009) Notch signaling controls the balance of ciliated and secretory cell fates in developing airways. Development136: 2297–230719502490|
|63.||Gridley T, (Year: 2007) Notch signaling in vascular development and physiology. Development134: 2709–271817611219|
|64.||Hirashima M, (Year: 2009) Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling. Anat Sci Int84: 95–10119259767|
|65.||Kallapur SG,, Bachurski CJ,, Le Cras TD,, Joshi SN,, Ikegami M,, et al. (Year: 2004) Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol287: L1178–118515321788|
|66.||Matute-Bello G,, Frevert CW,, Martin TR, (Year: 2008) Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol295: L379–39918621912|
|67.||Brain JD,, Molina RM,, DeCamp MM,, Warner AE, (Year: 1999) Pulmonary intravascular macrophages: their contribution to the mononuclear phagocyte system in 13 species. Am J Physiol276: L146–1549887067|
|68.||Romero R,, Yoon BH,, Mazor M,, Gomez R,, Diamond MP,, et al. (Year: 1993) The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol169: 805–8167694461|
|69.||DiGiulio DB,, Romero R,, Amogan HP,, Kusanovic JP,, Bik EM,, et al. (Year: 2008) Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One3: e305618725970|
|70.||Hitti J,, Riley DE,, Krohn MA,, Hillier SL,, Agnew KJ,, et al. (Year: 1997) Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor. Clin Infect Dis24: 1228–12329195088|
|71.||Coalson JJ, (Year: 2006) Pathology of bronchopulmonary dysplasia. Semin Perinatol30: 179–18416860157|
|72.||Van Marter LJ,, Dammann O,, Allred EN,, Leviton A,, Pagano M,, et al. (Year: 2002) Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr140: 171–17611865267|
|73.||De Paepe ME,, Greco D,, Mao Q, (Year: 2010) Angiogenesis-related gene expression profiling in ventilated preterm human lungs. Exp Lung Res36: 399–41020718599|
|74.||Thomas W,, Seidenspinner S,, Kramer BW,, Kawczynska-Leda N,, Chmielnicka-Kopaczyk M,, et al. (Year: 2009) Airway concentrations of angiopoietin-1 and endostatin in ventilated extremely premature infants are decreased after funisitis and unbalanced with bronchopulmonary dysplasia/death. Pediatr Res65: 468–47319127216|
|75.||Lazarus A,, Del-Moral PM,, Ilovich O,, Mishani E,, Warburton D,, et al. (Year: 2011) A perfusion-independent role of blood vessels in determining branching stereotypy of lung airways. Development138: 2359–236821558382|
|76.||Kramer BW,, Kramer S,, Ikegami M,, Jobe AH, (Year: 2002) Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol283: L452–45912114208|
|77.||Waldorf KM,, Gravett MG,, McAdams RM,, Paolella LJ,, Gough GM,, et al. (Year: 2011) Choriodecidual group B streptococcal inoculation induces fetal lung injury without intra-amniotic infection and preterm labor in Macaca nemestrina. PLoS One6: e2897222216148|
|78.||Gravett MG,, Witkin SS,, Haluska GJ,, Edwards JL,, Cook MJ,, et al. (Year: 1994) An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol171: 1660–16677802084|
|79.||Adams Waldorf KM,, Persing D,, Novy MJ,, Sadowsky DW,, Gravett MG, (Year: 2008) Pretreatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci15: 121–12718187405|
|80.||Morris AE,, Liggitt HD,, Hawn TR,, Skerrett SJ, (Year: 2009) Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol297: L1112–111919801452|
|81.||Chang J,, Jain S,, Carl DJ,, Paolella L,, Darveau RP,, et al. (Year: 2010) Differential host response to LPS variants in amniochorion and the TLR4/MD-2 system in Macaca nemestrina. Placenta31: 811–81720619890|
|82.||Gentleman RC,, Carey VJ,, Bates DM,, Bolstad B,, Dettling M,, et al. (Year: 2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol5: R8015461798|
|83.||Zhijin W,, Irizarry RA,, Gentleman R,, Martinez-Murillo F,, Spencer F, (Year: 2004) A model based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc99: 909–917|
|84.||Smyth GK, (Year: 2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol3: Article316646809|
|85.||Tusher VG,, Tibshirani R,, Chu G, (Year: 2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A98: 5116–512111309499|
|86.||Efron B, Tibshirani R (2006) On testing the significance of sets of genes. Available: http://www-stat.stanford.edu/~tibs/ftp/GSA.pdf|
|87.||Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, editors. (2005) Bioinformatics and computational biology solutions using R and Bioconductor. New York; London: Springer.|
|88.||Subramanian A,, Tamayo P,, Mootha VK,, Mukherjee S,, Ebert BL,, et al. (Year: 2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A102: 15545–1555016199517|
|89.||Camon E,, Magrane M,, Barrell D,, Lee V,, Dimmer E,, et al. (Year: 2004) The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res32: D262–26614681408|
|90.||Diaz D,, Krejsa CM,, White CC,, Keener CL,, Farin FM,, et al. (Year: 2001) Tissue specific changes in the expression of glutamate-cysteine ligase mRNAs in mice exposed to methylmercury. Toxicol Lett122: 119–12911439218|
|91.||Lin YS,, Dowling AL,, Quigley SD,, Farin FM,, Zhang J,, et al. (Year: 2002) Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol62: 162–17212065767|
|92.||Kevil CG,, Pruitt H,, Kavanagh TJ,, Wilkerson J,, Farin F,, et al. (Year: 2004) Regulation of endothelial glutathione by ICAM-1: implications for inflammation. Faseb J18: 1321–132315180961|
Table 1 Correlation between fetal lung score, amniotic fluid and fetal cytokines, culture results and labor.
|Group||Fetal Lung Score||Peak Amniotic Fluid||Peak Fetal Plasma||InoculationSite Culture||Chorio-amnionitis||Labor||Amniotic Fluid|
|IL-6(ng/ml)||IL-8(ng/ml)||IL-6(pg/ml)||IL-8(pg/ml)||Culture*||PCR* for GBS|
|GBS 1||4||77.9||19.3||11.3||563.5||100 CFU GBS||Yes||Yes||No Growth||Negative|
|GBS 2||2||102.6||6.3||7.5||558.1||No Growth||Yes||Yes||No Growth||Negative|
|GBS 3||3||88.1||27.2||3.1||1,975.2||1,000 CFU GBS||No||No||No Growth||Negative|
|GBS 4||0||13.8||3.6||0||3,142.8||No Growth||No||No||No Growth||Negative|
|GBS 5||3||80.8||8.5||2.6||1,606.5||No Growth||No||No||No Growth||Negative|
|Saline 1||0||8.3||1.0||**||**||No Growth||No||No||No Growth||Negative|
|Saline 2||2||16.0||1.6||2.0||523.4||No Growth||No||No||No Growth||Negative|
|Saline 3||1||3.0||0.5||**||**||No Growth||No||No||No Growth||Negative|
|Saline 4||0||10.3||1.6||0.9||182.3||No Growth||No||No||No Growth||Negative|
|Saline 5||0||11.7||1.9||2.4||223.0||No Growth||No||No||No Growth||Negative|
*Serial cultures of amniotic fluid were tested during the course of the experiment with approximately 10 samples tested per animal. Quantitative real-time PCR was performed on serially sampled amniotic fluid at three points in the course of the experiment including the day prior to inoculation, day of Cesarean section and once during the course of the experiment.
Table 2 Examples of most differentially regulated single genes.
|ProbeSetID||Rhesus Ensembl ID||log2 fold change||RhesusEntrez gene||Description||Symbol|
|MmuSTS.4444.1.S1_at||–||−1.95||722683||similar to Kallikrein-7 precursor (hK7) (Stratum corneum chymotryptic enzyme) (hSCCE)||LOC722683|
|Mmu.8081.1.S1_at||ENSMMUG00000012324///ENSMMUG00000013098||−1.90||706406///713150||similar to aldo-keto reductase family 1, member B10///similarto aldo-keto reductase family 1, member B10||LOC706406///LOC713150|
|Mmu.8081.1.S1_x_at||ENSMMUG00000012324||−1.40||713150||similar to aldo-keto reductase family 1, member B10||LOC713150|
|MmugDNA.36075.1.S1_at||ENSMMUG00000018680||−1.15||702126||potassium voltage-gatedchannel, shaker-relatedsubfamily, member 2||KCNA2|
|MmuSTS.2685.1.S1_s_at||–-||2.08||702712||similar to G protein-coupled receptor 109A||LOC702712|
|Mmu.11363.1.S1_at||ENSMMUG00000020903||2.10||574243||chemokine (C-X-C motif) ligand 10||CXCL10|
|MmugDNA.5658.1.S1_at||ENSMMUG00000003364||2.27||712571||BCL2-related protein A1||BCL2A1|
|MmuSTS.652.1.S1_at||ENSMMUG00000019778||2.28||704701||interleukin 1, beta||IL1B|
|MmuSTS.921.1.S1_at||ENSMMUG00000002037||2.34||703653||matrix metallopeptidase 1 (interstitial collagenase)||MMP1|
|MmuSTS.2150.1.S1_at||ENSMMUG00000011218||2.38||574106||serpin peptidase inhibitor,clade A (alpha-1 antiproteinase, antitrypsin), member 3||SERPINA3|
|Mmu.2053.1.S1_s_at||ENSMMUG00000030216||2.39||619514||chemokine (C-C motif) ligand 3||CCL3|
|MmugDNA.18432.1.S1_at||ENSMMUG00000019304||2.96||574370||indoleamine 2,3-dioxygenase 1||IDO1|
Table 3 Gene sets upregulated after GBS exposure relative to the control group.
|Gene set description||Gene set length||Gene Ontology ID||p value|
|pyrimidine base metabolic process||24||GO:0006206||<0.002|
|leukotriene metabolic process||11||GO:0006691||<0.002|
|cellular aromatic compound metabolic process||8||GO:0006725||<0.002|
|phospholipid catabolic process||15||GO:0009395||<0.002|
|pyrimidine nucleoside salvage||9||GO:0043097||<0.002|
|positive regulation of innate immune response||15||GO:0045089||0.002|
|pyrimidine base metabolic process||24||GO:0006206||0|
|neuropeptide hormone activity||27||GO:0005184||<0.002|
|hyaluronic acid binding||21||GO:0005540||<0.002|
|pancreatic ribonuclease activity||8||GO:0004522||0.006|
|organic anion transmembrane transporter activity||15||GO:0008514||0.006|
|dendritic spine membrane||5||GO:0032591||0.018|
|intrinsic to internal side of plasma membrane||11||GO:0031235||0.019|
|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex||13||GO:0032281||0.019|
Table 4 Gene sets downregulated after GBS exposure relative to the control group.
|Gene set description||Gene set length||Gene Ontology ID||p value|
|positive regulation of receptor recycling||5||GO:0001921||0.008|
|blood vessel maturation||5||GO:0001955||0.008|
|chromatin assembly or disassembly||38||GO:0006333||0.008|
|small GTPase mediated signal transduction||301||GO:0007264||0.008|
|carnitine metabolic process||7||GO:0009437||0.008|
|microtubule organizing center organization||5||GO:0031023||0.008|
|substrate adhesion-dependent cell spreading||19||GO:0034446||0.008|
|protein ubiquitination involved in ubiquitin-dependent protein catabolic process||45||GO:0042787||0.008|
|stress fiber assembly||8||GO:0043149||0.008|
|cardiac muscle tissue development||12||GO:0048738||0.008|
|proline-rich region binding||16||GO:0070064||0.008|
|positive transcription elongation factor activity||7||GO:0008159||0.010|
|acid-amino acid ligase activity||79||GO:0016881||0.010|
|histone acetyltransferase binding||15||GO:0035035||0.011|
|growth factor binding||39||GO:0019838||0.012|
|transmembrane receptor protein tyrosine kinase activity||54||GO:0004714||0.013|
|transforming growth factor beta receptor activity||18||GO:0005024||0.013|
|two-component sensor activity||14||GO:0000155||0.014|
|clathrin adaptor complex||23||GO:0030131||0.009|
|CUL4 RING ubiquitin ligase complex||11||GO:0080008||0.013|
|AP-type membrane coat adaptor complex||6||GO:0030119||0.018|
Table 5 Ingenuity Pathway Analysis Summary.
|Functional Analysis of a Network*|
|Diseases and Disorders||Number of Molecules||p value|
|Connective tissue disorders||144||7.39×10−32–1.16×10−6|
|Skeletal and muscular disorders||144||7.39×10−32–1.16×10−6|
|Molecular and Cellular Functions|
|Cell-to-cell signaling and interaction||138||1.06×10−36–3.77×10−6|
|Cellular growth and proliferation||187||4.31×10−26–2.29×10−6|
|Immune cell trafficking||126||7.27×10−39–3.77×10−6|
|Hematological system development||168||4.91×10−36–3.77×10−6|
|Canonical Pathway Analysis**|
|Top Canonical Pathways||Ratio||p value|
|Antigen presentation pathway||13/43||3.93×10−13|
|Dendritic cell maturation||22/188||3.99×10−12|
|Allograft rejection signaling||12/96||4.72×10−11|
|Communication between innate and adaptive immune cells||15/109||8.28×10−11|
|Transcription Factor Analysis***|
|Top Transcription Factors||Predicted Activation State||p-value of overlap|
*The Functional Analysis of a Network identified biological functions and/or diseases that were most significant to the molecules in the network using a right-tailed Fisher’s exact test.
**Canonical Pathway Analysis identified pathways from the IPA library that were most significant to the data set. Significance of the association was measured in two ways: (1) as the ratio of the number of molecules from the focus gene set that map to the pathway to the total number of molecules that map to the canonical pathway and (2) using Fisher’s exact test.
***Transcription factor analysis is based on prior knowledge of expected effects between transcription factors and their target genes stored in the IPA library. The overlap p-value measures whether there is a statistically significant overlap between the dataset genes and the genes regulated by a transcription factor using Fisher’s Exact Test.
Previous Document: Selection and application of ssDNA aptamers to detect active TB from sputum samples.
Next Document: The oligonucleotide binding (OB)-fold domain of KREPA4 is essential for stable incorporation into ed...